F, Wang and L-Y, Shen contributed equally to this work.
Advantages of positron emission tomography-computed tomography imaging in esophageal squamous cell carcinoma
Article first published online: 4 SEP 2012
© 2012 Copyright the Authors. Journal compilation © 2012, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus
Diseases of the Esophagus
Volume 26, Issue 8, pages 832–837, November/December 2013
How to Cite
Wang, F., Shen, L.-Y., Ma, S.-H., Li, N., Yang, Z. and Chen, K.-N. (2013), Advantages of positron emission tomography-computed tomography imaging in esophageal squamous cell carcinoma. Diseases of the Esophagus, 26: 832–837. doi: 10.1111/j.1442-2050.2012.01407.x
Conflicts of interest: None declared.
Conception and design: Ke-Neng Chen.
Major executer of study: Ke-Neng Chen, Fei Wang.
Provision of Patients: Ke-Neng Chen, Fei Wang, Shao-Hua Ma, Lu-Yan Shen, Nan Li, Zhi Yang.
Collection and assembly of data: Ke-Neng Chen, Fei Wang, Shao-Hua Ma, Nan Li, Zhi Yang.
Data analysis and interpretation: Ke-Neng Chen, Fei Wang, Shao-Hua Ma, Lu-Yan Shen.
Manuscript writing: Ke-Neng Chen, Lu-Yan Shen.
Final approval of manuscript: Ke-Neng Chen, Fei Wang, Shao-Hua Ma, Lu-Yan Shen, Nan Li, Zhi Yang.
- Issue published online: 14 NOV 2013
- Article first published online: 4 SEP 2012
- Beijing Academic Leaders Program. Grant Number: 2009-2-17
- Beijing Natural Science Foundation. Grant Number: 7102029
- Capital Medical Development Research Found. Grant Number: 2007–1023
- New Scholar Star Program of Ministry of Education, and National Basic Research Program of China. Grant Number: 2011CB504300
- esophageal squamous cell carcinoma;
- response evaluation
To explore the value of positron emission tomography-computed tomography (PET-CT) scan in esophageal squamous cell carcinoma (ESCC), we retrospectively summarize the results of PET-CT scan from 118 patients, with ESCC who underwent PET-CT scan in the different courses during treatment. Then, the results of PET-CT scan plus other conventional methods were analyzed to identify the value of PET-CT scan in diagnosis, staging, response evaluation, monitoring recurrence, and metastasis following treatment. It is suggested that PET-CT scan possess high value in diagnosis and gives more favorable indication in N and M staging. PET-CT scan should be translated into routine surveillance for postoperation follow up and is one of more helpful evaluators of response to chemoradiotherapy or chemotherapy.